Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension.
Ochi H, Niino M, Onizuka Y, Hiramatsu K, Hase M, Yun J, Matta A, Torii S. Ochi H, et al. Among authors: onizuka y. Adv Ther. 2018 Oct;35(10):1598-1611. doi: 10.1007/s12325-018-0788-8. Epub 2018 Sep 11. Adv Ther. 2018. PMID: 30206820 Free PMC article. Clinical Trial.
Efficacy and safety of dimethyl fumarate in treatment-naïve Japanese patients with multiple sclerosis: Interim analysis of the randomized placebo-controlled study.
Mori M, Ohashi T, Onizuka Y, Hiramatsu K, Hase M, Yun J, Matta A, Torii S. Mori M, et al. Among authors: onizuka y. Mult Scler J Exp Transl Clin. 2019 Jun 10;5(2):2055217319852727. doi: 10.1177/2055217319852727. eCollection 2019 Apr-Jun. Mult Scler J Exp Transl Clin. 2019. PMID: 31218077 Free PMC article.
Efficacy of dimethyl fumarate in Japanese multiple sclerosis patients: interim analysis of randomized, double-blind APEX study and its open-label extension.
Kondo T, Kawachi I, Onizuka Y, Hiramatsu K, Hase M, Yun J, Matta A, Torii S. Kondo T, et al. Among authors: onizuka y. Mult Scler J Exp Transl Clin. 2019 Jul 31;5(3):2055217319864974. doi: 10.1177/2055217319864974. eCollection 2019 Jul-Sep. Mult Scler J Exp Transl Clin. 2019. PMID: 31391949 Free PMC article.
Differential cardiomyocyte transcriptomic remodeling during in vitro Trypanosoma cruzi infection using laboratory strains provides implications on pathogenic host responses.
Candray-Medina KS, Nakagama Y, Ito M, Nakagama S, Tshibangu-Kabamba E, Takeda N, Sugiura Y, Nitahara Y, Michimuko-Nagahara Y, Kaku N, Onizuka Y, Arias CE, Mejia M, Alas K, Peña S, Maejima Y, Komuro I, Nakajima-Shimada J, Kido Y. Candray-Medina KS, et al. Among authors: onizuka y. Trop Med Health. 2023 Dec 7;51(1):68. doi: 10.1186/s41182-023-00552-6. Trop Med Health. 2023. PMID: 38062533 Free PMC article.
Re-emerging threat of Trypanosoma cruzi vector transmission in El Salvador, update from 2018 to 2020.
Rodríguez MS, Nitahara Y, Cornejo M, Siliezar K, Grande R, González A, Tasaki K, Nakagama Y, Michimuko Y, Onizuka Y, Nakajima-Shimada J, Romero JE, Palacios JR, Arias CE, Mejía W, Kido Y, Cardona Alvarenga R. Rodríguez MS, et al. Among authors: onizuka y. Infect Dis Poverty. 2022 Aug 9;11(1):89. doi: 10.1186/s40249-022-01008-5. Infect Dis Poverty. 2022. PMID: 35945552 Free PMC article.
54 results